Market Cap (In SEK)
21.81 Billion
Revenue (In SEK)
331.73 Million
Net Income (In SEK)
9.84 Million
Avg. Volume
589.15 Thousand
- Currency
- SEK
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 25.14-47.2
- PE
- -
- EPS
- -
- Beta Value
- 1.597
- ISIN
- SE0015961982
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Mr. Patrik Eriksson
- Employee Count
- -
- Website
- https://vimian.com
- Ipo Date
- 2021-06-18
- Details
- Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name. It also provides procurement and tech-driven operations, such as online marketing, and education and HR, as well as a community for veterinary clinics through a membership-based platform under the VetFamily brand name; and orthopedic implants for veterinarians and universities under the Movora brand name. The company was incorporated in 2020 and is headquartered in Stockholm, Sweden.
More Stocks
-
E
-
6548Tabikobo Co. Ltd.
6548
-
TEL2-BTele2 AB (publ)
TEL2-B
-
6245
-
YRAIFYara International ASA
YRAIF
-
INTZIntrusion Inc.
INTZ
-
085620
-
NDBKFNedbank Group Limited
NDBKF